Loading viewer...
investor_presentation
Format: PDF investor_presentation
ImmunityBio presents updates on ANKTIVA approval and commercial launch, global regulatory filing status, and safety and efficacy data. The presentation covers ANKTIVA mechanism of action, BCG naïve clinical data, and manufacturing partnership with Serum Institute of India, alongside the company's pipeline overview.
investor_presentation
31 Pages
PARTS iD
Otis Worldwide 2022 ESG Investor Presentation
investor_presentationinvestor_presentation
11 Pages
Otis Worldwide Corporation
